M. Kekilli Et Al. , "Dasatinib-Induced Severe Hemorrhagic Colitis in Chronic Myeloid Leukemia," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.1, pp.67-68, 2016
Kekilli, M. Et Al. 2016. Dasatinib-Induced Severe Hemorrhagic Colitis in Chronic Myeloid Leukemia. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.1 , 67-68.
Kekilli, M., Tanoglu, A., Cakar, M. K., Guney, G., & HAZNEDAROĞLU, İ. C., (2016). Dasatinib-Induced Severe Hemorrhagic Colitis in Chronic Myeloid Leukemia. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.1, 67-68.
Kekilli, MURAT Et Al. "Dasatinib-Induced Severe Hemorrhagic Colitis in Chronic Myeloid Leukemia," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.1, 67-68, 2016
Kekilli, MURAT Et Al. "Dasatinib-Induced Severe Hemorrhagic Colitis in Chronic Myeloid Leukemia." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.1, pp.67-68, 2016
Kekilli, M. Et Al. (2016) . "Dasatinib-Induced Severe Hemorrhagic Colitis in Chronic Myeloid Leukemia." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.1, pp.67-68.
@article{article, author={MURAT KEKİLLİ Et Al. }, title={Dasatinib-Induced Severe Hemorrhagic Colitis in Chronic Myeloid Leukemia}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2016, pages={67-68} }